Bringing the next level of technology integration to clinical development, Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has launched its industry-leading eClinical Suite to provide truly seamless integration and access to data across multiple technologies throughout the trial process. A unique combination of Perceptive’s leading products and services, the suite is designed to realize the full potential of eClinical, yielding increased value and utility by creating an environment for more effective management and operation of clinical trials.
Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has introduced a new reporting solution as part of its ClinPhone Randomization and Trial Supply Management (RTSM) technologies, which offer validated randomization methods, automated inventory control, dispensing and titration management, and emergency code break capabilities.
Download PDF
PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Wachovia 19th Annual Mid-Year Equity Conference in Boston. James Winschel, Senior Vice President & Chief Financial Officer will be making a formal presentation on PAREXEL at 10:15 a.m. EDT on Tuesday, June 23, 2009
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has appointed Lars-Olof Eriksson, Ph.D., MS.c., to the position of Vice President of its Start-up and Accelerated Recruitment Team (START). Formerly a Senior Director in Clinical Research Operations specializing in patient recruitment at Merck & Co., Inc., Dr. Eriksson leads a global team of PAREXEL experts in providing a strategic, comprehensive approach to accelerate study initiation and achieve last patient in (LPI) milestones for regional and international clinical trials conducted by PAREXEL for its clients.
Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association (DIA) 45th Annual Meeting, being held from June 21 – 25, 2009 in San Diego, California.
Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced the launch of a website designed to help investigators apply the new 1.1 version of RECIST (Response Evaluation Criteria In Solid Tumors) in medical imaging-based oncology trials.
PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Goldman Sachs 30th Annual Global Healthcare Conference in New York. Josef von Rickenbach, Chairman & Chief Executive Officer will be making a formal presentation on PAREXEL at 3:10 p.m. EDT on Tuesday, June 9, 2009.
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has reached a milestone in managing oncology-based clinical trials over the last five years, which have involved over 175,000 patients in hundreds of programs across 80 countries. PAREXEL will be marking this milestone during the American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2009 in Orlando, Florida.
Experts from PAREXEL Consulting will present insights into achieving regulatory approval at the BIO International Convention, to be held May 18 -21, 2009 at the Georgia World Congress Center in Atlanta, Georgia. PAREXEL Consulting is a business unit of PAREXEL International (NASDAQ: PRXL) and leading global consultancy serving the biopharmaceutical and medical device industries.
Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced the results of a survey conducted during its recent webinar entitled “Optimizing Adaptive Trial Designs: Using Simulation Methodologies to Overcome Challenges.”
Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has developed a robust medical imaging methodology for Central Nervous System (CNS) clinical trials involving Alzheimer’s disease.
For the three months ended March 31, 2009, PAREXEL’s consolidated service revenue increased 7.8% to $264.5 million, compared with $245.3 million in the prior year period. Foreign exchange negatively impacted the quarter by $35.7 million dollars. Excluding the negative impact of foreign exchange and the net positive impact of acquisitions and divestitures of $17.0 million from the third quarter of Fiscal Year 2009, and $0.9 million in divestitures from the third quarter of Fiscal Year 2008, revenue grew 15.8% year-over-year.
Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will present key industry topics during the 18th Annual Partnerships with CROs and Other Outsourcing Providers Conference, to be held April 28 - 30, 2009 at the Rosen Shingle Creek Hotel in Orlando, Florida.
Boston, MA, April 2, 2009 – Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has expanded the number of languages supported by its ClinPhone Interactive Web Response System (IWRS) including Japanese Kanji, the Chinese characters used in the Japanese writing system.
Boston, MA, March 26, 2009 – PAREXEL International Corporation (NASDAQ: PRXL) will release Third Quarter Fiscal Year 2009 financial results on Monday, April 27, 2009 after the close of the stock market.
Dowload PDF
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has received the Best Performing Clinical Research Organization (CRO) Award from BioSingapore, an industry association for life sciences businesses encouraged by the Economic Development Board of Singapore.
Boston, MA, March 16, 2009 – PAREXEL experts will address the benefits of rigorous early phase clinical development at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), to be held at the Gaylord National Resort in National Harbor, Maryland from March 18 - 21, 2009.
Boston, MA, March 12, 2009 – Albert Liou, Corporate Vice President and General Manager, Asia/Pacific Region at PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will present “The True Value of Incorporating Asia into a Global Clinical Development Strategy” at the BioMedical Asia 2009 conference, to be held March 16 - 19, 2009 at the Suntec Singapore International Convention & Exhibition Centre in Singapore.
Boston, MA, March 5, 2009 – Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association (DIA) 21st Annual EuroMeeting, being held from March 23 – 25, 2009 in Berlin, Germany.
Boston, MA, March 3, 2009 – PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Raymond James 30th Annual Institutional Investors Conference in Orlando, Florida. PAREXEL will also be presenting at the Barclays Capital Global Healthcare Conference in Miami, Florida.
Boston, MA, February 24, 2009 – Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has received the Frost & Sullivan Product Line Strategy Award.
PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and leading global consultancy serving the biopharmaceutical and medical device industries, has appointed Anders Neil, Ph.D., to the position of Principal Consultant in its European Product Development Practice. Dr. Neil, former Senior Expert, Pharmacology and Toxicology, at Sweden’s Medical Products Agency (MPA), will advise clients on all aspects of clinical development and regulatory affairs.
Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced it has established an alliance with AG Mednet, a global diagnostic imaging network, to bring greater efficiency to the electronic transport of medical images and a higher level of quality to imaging data.
Perceptive Informatics (Perceptive), the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has reached a key milestone, with 10 million calls placed through its ClinPhone Interactive Voice Response System (IVRS) over the past seven years in support of clinical trials for its clients. Perceptive’s IVRS technology manages important clinical trial functions, including patient enrollment and randomization as well as study drug inventory management.
Experts from PAREXEL Consulting, a leading global consultancy serving the biopharmaceutical and medical device industries, and business unit of PAREXEL International (NASDAQ: PRXL), will present key insights related to the early-stage development of therapeutic vaccines today at the Phaciliate Vaccines Forum. PAREXEL consulting experts will discuss the development of follow-on biologics as part of a Windover Webinar scheduled for February 5, 2009.
PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the second quarter ended December 31, 2008.
PAREXEL International Corporation (NASDAQ: PRXL) will release Second Quarter Fiscal Year 2009 financial results on Monday, January 26, 2009 after the close of the stock market. Download PDF
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, announced today it has appointed Josephine Hoppe as Corporate Vice President and Chief Information Officer (CIO). Download PDF
PAREXEL International Corporation (NASDAQ: PRXL) has received notification from a small biopharma client that it will be unable to continue to make payments that are due to PAREXEL in connection with an on-going service contract for a large Phase III clinical trial. Download PDF
PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the 27th Annual JP Morgan Healthcare Conference at The Westin St. Francis in San Francisco.
Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has entered into a license agreement with the EuroQoL Group.Download PDF Read the Press Release
